Tresam Capital (@TresamC) profile picture

Tresam Capital

@TresamC

Private Equity Fund | Capital Management

 Mexico | USA
tresamcapital.com
Joined February 2021
  • Tweets20
  • Following154
  • Followers34
For those of you not able to hear my talk at AAIC, here is a great write-up of the simufilam data on Seeking Alpha. With all the caveats of an open-label study, $SAVA #ENDAlz seekingalpha-com.cdn.ampproj…
10
25
5
94
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease $SAVA #ENDALZ #AAIC2021 cassavasciences.com/node/154…
7
24
6
102
Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer’s Disease cassavasciences.com/node/154… $SAVA #ENDALZ #AAIC2021
2
17
2
64
On Thursday, July 29th, at approximately 11 am ET, simufilam will be featured in a live podium presentation at AAIC Watch and Listen Live to : Lindsay H. Burns PhD - Sr. VP, Neuroscience Share encouraging 9month Simufilam data $SAVA #AAIC2021
7
43
4
104
Looking forward seeing you at #AAIC21 ! $SAVA @alzassociation -On Monday, July 26th, New Clinical Data for SavaDx to be Shared in a Poster presentation - On Thursday, July 29th, Encouraging new Clinical Data for Simufilam to be Featured in a Podium Presentation
5
28
3
82
Looking forward for you to Tune in next week for our Podium Presentation. The Alzheimer’s Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science. @alzassociation $SAVA #ENDALZ I
3
30
5
82
Tresam Capital retweeted
Seeking Alpha (@SeekingAlpha) profile picture
Seeking Alpha
@SeekingAlpha20 Jul 2021
$SAVA - Cassava Sciences Is On The Brink Of Making Medical History. seekingalpha.com/article/444… #finance #trading #investing

Cassava Sciences Is On The Brink Of Making Medical History (NASDAQ:SAVA) | Seeking Alpha

Cassava Sciences has the proper science to take on a $100 billion industry desperately in need of new approaches.

seekingalpha.com
4
2
7
The National Institutes of Health (NIH) continues to provide our research programs with substantial scientific and financial support.  Academics and scientific and medical advisors supply us with substantial technical support #ENDAlz $SAVA
18
45
Cassava to release further analysis of Alzheimer's drug simufilam in July | Seeking Alpha $SAVA seekingalpha.com/news/368408…
Breaking Stock Market & Investing News | Seeking Alpha

Breaking Stock Market & Investing News | Seeking Alpha

Breaking news and real-time stock market updates from Seeking Alpha. Check out the latest investing news and financial headlines.

seekingalpha.com
Cassava initiated with a buy and $110 PT at Jones Trading | Seeking Alpha $SAVA seekingalpha.com/news/367353…
4
Tresam Capital retweeted
WSJ Markets (@WSJmarkets) profile picture
WSJ Markets
@WSJmarkets11 Mar 2021
Heard on the Street: It’s hard to find a real estate market around the world that isn’t booming on.wsj.com/2OLTgbW
2
9
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam | Cassava Sciences, Inc. $SAVA cassavasciences.com/news-rel…

Investor Relations | Filana Therapeutics, Inc.

The Investor Relations website contains information about Filana Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

filanatx.com
$SAVA Cassava Sciences: Early To Market In Alzheimer's (NASDAQ:SAVA) | Seeking Alpha seekingalpha.com/article/441…
1
All this $CCIV $NIO EV fever doesn’t make that much sense. What does the market expect Ford $F or $GM that have been around for 100+ years do? Just sit and watch? They will come. Crazy valuations if you put thing into perspective.
$SAVA very interesting interview with Cassava Sciences CEO. Sumifilam (Alzheimer Drug) is huge. Very undervalued by the market to this day. Huge growth potential fb.watch/3_77Ag-snD/
Load more